Compile Data Set for Download or QSAR
Report error Found 97 Enz. Inhib. hit(s) with all data for entry = 50008598
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075146((E)-3-(2,5-Dimethyl-thiophen-3-yl)-N-[(S)-1-(5-met...)
Affinity DataIC50: 7nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075158((E)-3-(5-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 8nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075166((E)-3-(2,6-Dichloro-phenyl)-N-[(S)-1-(5-methyl-4-o...)
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075154((E)-3-(2-Ethoxy-phenyl)-N-[(S)-1-(5-methyl-4-oxo-4...)
Affinity DataIC50: 15nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075152((E)-3-(2-Chloro-4-hydroxy-phenyl)-N-[(S)-1-(5-meth...)
Affinity DataIC50: 15nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075163((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 16nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075138((E)-3-(5-Chloro-thiophen-2-yl)-N-[(S)-1-(5-methyl-...)
Affinity DataIC50: 17nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075159((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 19nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075165((E)-3-(3,5-Dimethoxy-phenyl)-N-[(S)-1-(5-methyl-4-...)
Affinity DataIC50: 21nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075148((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 29nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075136((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 33nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075167((E)-3-(4-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 33nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075143((E)-3-(2-Chloro-phenyl)-N-[(S)-1-(5-methyl-4-oxo-4...)
Affinity DataIC50: 35nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075137((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 36nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075156((E)-3-(2-Chloro-6-fluoro-phenyl)-N-[(S)-1-(5-methy...)
Affinity DataIC50: 36nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075151(N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]oxaz...)
Affinity DataIC50: 37nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075161((E)-3-(4-Dimethylamino-phenyl)-N-[(S)-1-(5-methyl-...)
Affinity DataIC50: 38nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075164((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 38nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075157((E)-3-(2-Bromo-phenyl)-N-[(S)-1-(5-methyl-4-oxo-4H...)
Affinity DataIC50: 39nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075162((E)-3-(5-Bromo-furan-2-yl)-N-[(S)-1-(5-methyl-4-ox...)
Affinity DataIC50: 41nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075142(N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]oxaz...)
Affinity DataIC50: 42nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075169((E)-3-(3-Chloro-phenyl)-N-[(S)-1-(5-methyl-4-oxo-4...)
Affinity DataIC50: 42nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075155((E)-3-(2-Bromo-thiophen-3-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 51nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075149((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 54nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075168((E)-3-(3-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 58nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075145((E)-3-(2,6-Difluoro-phenyl)-N-[(S)-1-(5-methyl-4-o...)
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075144((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075141((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 76nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075140((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 89nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075153((E)-3-(4-Formyl-phenyl)-N-[(S)-1-(5-methyl-4-oxo-4...)
Affinity DataIC50: 94nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075142(N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]oxaz...)
Affinity DataIC50: 110nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGenome polyprotein(Human rhinovirus B)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075160((Z)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 140nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) herpes protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075150((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 170nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-4)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075162((E)-3-(5-Bromo-furan-2-yl)-N-[(S)-1-(5-methyl-4-ox...)
Affinity DataIC50: 180nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075139((E)-3-(2,6-Dimethoxy-phenyl)-N-[(S)-1-(5-methyl-4-...)
Affinity DataIC50: 180nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075167((E)-3-(4-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 190nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075146((E)-3-(2,5-Dimethyl-thiophen-3-yl)-N-[(S)-1-(5-met...)
Affinity DataIC50: 190nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075155((E)-3-(2-Bromo-thiophen-3-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 200nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075138((E)-3-(5-Chloro-thiophen-2-yl)-N-[(S)-1-(5-methyl-...)
Affinity DataIC50: 210nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-4)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075158((E)-3-(5-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 210nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-4)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075148((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 220nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-4)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075146((E)-3-(2,5-Dimethyl-thiophen-3-yl)-N-[(S)-1-(5-met...)
Affinity DataIC50: 230nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075152((E)-3-(2-Chloro-4-hydroxy-phenyl)-N-[(S)-1-(5-meth...)
Affinity DataIC50: 230nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075168((E)-3-(3-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 250nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075159((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 250nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-4)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075142(N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]oxaz...)
Affinity DataIC50: 250nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075163((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 260nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-2)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075158((E)-3-(5-Bromo-thiophen-2-yl)-N-[(S)-1-(5-methyl-4...)
Affinity DataIC50: 270nMAssay Description:Inhibitory activity against herpes simplex virus type 2 (HSV-2) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-4)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075138((E)-3-(5-Chloro-thiophen-2-yl)-N-[(S)-1-(5-methyl-...)
Affinity DataIC50: 280nMAssay Description:Inhibitory activity against cytomegalovirus (CMV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCapsid scaffolding protein(HHV-6 variant A)
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075147((E)-N-[(S)-1-(5-Methyl-4-oxo-4H-thieno[2,3-d][1,3]...)
Affinity DataIC50: 290nMAssay Description:Inhibitory activity against Varicella Zoster Virus (VZV) protease was determined using quenched fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 97 total ) | Next | Last >>
Jump to: